Secretaría de Gobernación
CONACYT
INGER
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17275
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0es_MX
dc.creatorDOLORES MINO LEONes_MX
dc.creatorHORTENSIA REYES MORALESes_MX
dc.creatorLUIS JASSO GUTIERREZes_MX
dc.creatorSVETLANA VLADISLAVOVNA DOUBOVAes_MX
dc.date2012-
dc.date.accessioned2021-10-26T22:41:10Z-
dc.date.available2021-10-26T22:41:10Z-
dc.identifier.urihttp://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17275-
dc.descriptionBackground Inappropriate prescription is a relevant problem in primary health care settings in Mexico, with potentially harmful consequences for patients. Objective To evaluate the effectiveness of incorporating a pharmacist into primary care health team to reduce prescription errors for patients with diabetes and/or hypertension. Setting One Family Medicine Clinic from the Mexican Institute of Social Security in Mexico City. Method A “pharmacotherapy intervention” provided by pharmacists through a quasi experimental (before–after) design was carried out. Physicians who allowed access to their diabetes and/or hypertensive patients’ medical records and prescriptions were included in the study. Prescription errors were classified as “filling”, “clinical” or “both”. Descriptive analysis, identification of potential drug–drug interactions (pD–DI), and comparison of the proportion of patients with prescriptions with errors detected “before” and “after” intervention were performed. Main outcome measure Decrease in the proportion of patients who received prescriptions with errors after the intervention. Results Pharmacists detected at least one type of error in 79 out of 160 patients. Errors were “clinical”, “both” and “filling” in 47, 21 and 11 of these patient’s prescriptions respectively. Predominant errors were, in the subgroup of patient’s prescriptions with “clinical” errors, pD–DI; in the subgroup of “both” errors, lack of information on dosing interval and pD–DI; and in the “filling” subgroup, lack of information on dosing interval. The pD–DI caused 50 % of the errors detected, from which 19 % were of major severity. The impact of the correction of errors post-intervention was observed in 19 % of patients who had erroneous prescriptions before the intervention of the pharmacist (49.3–30.3 %, p < 0.05). Conclusion The impact of the intervention was relevant from a clinical point of view for the public health services in Mexico. The implementation of early warning systems of the most widely prescribed drugs is an alternative for reducing prescription errors and consequently the risks they may cause.es_MX
dc.formatAdobe PDFes_MX
dc.languageenges_MX
dc.publisherSpringeres_MX
dc.relationhttps://link.springer.com/article/10.1007/s11096-012-9632-4es_MX
dc.relation.requiresSies_MX
dc.rightsAcceso Abiertoes_MX
dc.sourceInternational Journal of Clinical Pharmacy (2210-7711) Vol. 34 (2012)es_MX
dc.subjectMEDICINA Y CIENCIAS DE LA SALUDes_MX
dc.subjectCiencias médicases_MX
dc.subjectFarmacodinámicaes_MX
dc.subjectFarmacoterapiaes_MX
dc.subjectTerapia de drogases_MX
dc.subjectPrescripción de medicamentoses_MX
dc.subjectErrores de prescripciónes_MX
dc.subjectMédicos failiareses_MX
dc.subjectMéxicoes_MX
dc.subjectFamily doctorses_MX
dc.subjectPharmacotherapyes_MX
dc.subjectDrug therapyes_MX
dc.subjectDrug prescriptionses_MX
dc.subjectPrescription errorses_MX
dc.subjectMexicoes_MX
dc.titlePhysicians and pharmacists: collaboration to improve the quality of prescriptions in primary care in Mexicoes_MX
dc.typeArtículoes_MX
dc.audienceResearcherses_MX
dc.creator.idMILD650803MDFNNL06es_MX
dc.creator.idREMH510406MDFYRR02es_MX
dc.creator.idJAGL431012HDFSTS03es_MX
dc.creator.idDOXS690510MNEBXV08es_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
Aparece en las colecciones: 1. Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
International Journal of Clinical Pharmacy (2210-7711) Vol. 34 (2012).pdf170.61 kBAdobe PDFVisualizar/Abrir